The population of uninsured Americans reaches into the millions, and unfortunately that number seems to be growing each day. At TAP, we are connected to the problem, and we are passionate about assisting qualified patients to receive the medication they need.

We want to call your attention to TAP-sponsored programs designed to make our medications more accessible to patients. (Please refer to the program applications for a detailed description of the terms and conditions of participation):

For Prevacid (lansoprazole):

• The TAP Program provides a 90-100 day supply of Prevacid and/or Prevacid SoluTab (lansoprazole) at no charge to qualified patients.
• Patients are qualified for assistance with Prevacid if:
• They do not have private or public prescription drug coverage UNLESS that prescription coverage comes from a Medicare Part D Prescription Drug Plan.
• They are at or below 300% of the Federal Poverty Level (FPL). Medicare Part D participants must be between 135% of FPL and 300% of FPL.
• They are a legal U.S. Resident
• Qualified patients are enrolled in the program for a running 12 months. Medicare Part D participants who choose to participate in the TAP Program are enrolled for the remainder of the Medicare Part D enrollment calendar year.
• Medicare Part D participants must also agree to the following conditions:
• Qualified patients agree not to seek the requested medication from any Medicare Part D plan for the remainder of the enrollment calendar year.
• Qualified patients agree not to seek or accept reimbursement from any Part D plan for any medication received from the Program.
• Qualified patients agree not to seek true out-of-pocket (TrOOP) credit for any medication received from the Program because medication received from the Program will not count toward TrOOP.
• Qualified patients agree to give consent for the Program to disclose the patient’s enrollment in the Program to that patient’s Medicare Part D plan.
• Qualified patients agree to notify the Program immediately in writing if the patient’s prescription drug coverage changes in any way.

For Lupron Depot (leuprolide acetate for depot suspension):

• The TAP Program offers the requested dose of Lupron Depot at no charge to qualified patients.
• Patients are qualified for assistance with Lupron Depot if:
• They do not have private or public injectable drug coverage.
• They are at or below 300% of the Federal Poverty Level (FPL).
• They are a legal U.S. Resident
• Qualified patients are enrolled in the program for a running 12 months.

The TAP Patient Assistance Program goes a long way in helping qualified individuals obtain necessary medications.

To download the application and instructions for a request for assistance with your prescription, please click the appropriate application below.
Click here for Prevacid form
Click here for Lupron Depot form

Any patients or healthcare providers who have questions regarding the TAP Patient Assistance Program should contact the program directly at 1-800-830-1015.

Click here for further information about Prevacid and Lupron Depot.